← Back to Search

POST Facilitation for Post-Traumatic Stress Disorder (POST-RCT Trial)

N/A
Recruiting
Led By Alexia M Torke, MD, MS
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
65 or older
Patients must be 65 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed 12 months from the date that the patient receives post facilitation or home safety evaluation
Awards & highlights

Summary

This trial will study the effects of a Physician Orders for Scope of Treatment (POST) Facilitation in a population of older adults who qualify for it, including those with normal cognition and those with Alzheimer's Disease and related disorders.

Who is the study for?
This trial is for community-dwelling older adults aged 65 or above with certain serious health conditions like metastatic cancer, heart failure, kidney disease, COPD, or advanced Alzheimer's. They must have a high risk of mortality within a year and either be able to make decisions themselves or have a surrogate decision maker. Those already in hospice care or with an existing POST form are excluded.Check my eligibility
What is being tested?
The study is testing the effectiveness of Physician Orders for Scope of Treatment (POST) Facilitation compared to usual care in improving outcomes for older adults. It involves home safety evaluations and discussions about treatment preferences in case of severe illness.See study design
What are the potential side effects?
Since this trial focuses on treatment planning rather than medical interventions, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing end-of-life preferences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I am 65 years old or older.
Select...
My daily activities are limited due to my cancer.
Select...
I can make my own health decisions or have someone who can.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed 12 months from the date that the patient receives post facilitation or home safety evaluation
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed 12 months from the date that the patient receives post facilitation or home safety evaluation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Discordance between treatment preferences and treatment received 12 months after POST Facilitation
Secondary outcome measures
Decision conflict
Decision quality- ACP engagement
Decision quality- POLST Knowledge
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention (POST Facilitation)Experimental Treatment1 Intervention
A nurse will complete a home visit with the patient and their surrogate decision maker or other family (if they've designated one), in which he or she will provide education about the POST form. The POST facilitators will be nurses trained using the Respecting Choices Advanced Steps model.
Group II: Attention Control (Home Safety Evaluation)Experimental Treatment1 Intervention
A nurse will complete a home visit with the patient and their surrogate decision maker or other family member (if they've designated one), in which he or she will provide suggestions on how to improve the safety of the patient's home.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,736 Previous Clinical Trials
7,507,172 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,704 Previous Clinical Trials
28,032,479 Total Patients Enrolled
Regenstrief Institute, Inc.OTHER
26 Previous Clinical Trials
97,699 Total Patients Enrolled

Media Library

POST Facilitation Clinical Trial Eligibility Overview. Trial Name: NCT04070183 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Intervention (POST Facilitation), Attention Control (Home Safety Evaluation)
Post-Traumatic Stress Disorder Clinical Trial 2023: POST Facilitation Highlights & Side Effects. Trial Name: NCT04070183 — N/A
POST Facilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04070183 — N/A
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT04070183 — N/A
~30 spots leftby Oct 2024